Metastatic Penile Squamous Cell Carcinoma clinical trials

Explore recruiting metastatic penile squamous cell carcinoma clinical trials.

Recruiting metastatic penile squamous cell carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metastatic Penile Squamous Cell Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

DEPECA-1 – DEfeating PEnile CAncer 1 – A Phase II study to evaluate a first-line systemic therapy with enfortumab vedotin plus avelumab for advanced and metastatic penile carcinoma

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Metastatic Penile Squamous Cell Carcinoma trials by city

Metastatic Penile Squamous Cell Carcinoma clinical trials

Recruiting metastatic penile squamous cell carcinoma studies right now

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis

MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma

QL1706 Plus Lenvatinib in Previously Treated Penile Cancer

Also recruiting in Europe

DEPECA-1 – DEfeating PEnile CAncer 1 – A Phase II study to evaluate a first-line systemic therapy with enfortumab vedotin plus avelumab for advanced and metastatic penile carcinoma

Metastatic Penile Squamous Cell Carcinoma trials by city

Other conditions